Showing results (121-130 of 201) with videos related to
Sort By:
Pageof 21
Annals of Hematology|March 12, 2021
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantationArjun Datt Law, Sita Bhella, Ivan Pasic, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2008
Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cellsZhen Li, Scott R McKercher, Jiankun Cui, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2016
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched AnalysisHassan Sibai, Umberto Falcone, Uday Deotare, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2019
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host DiseaseRoman M Shapiro, Elizabeth Shin, Arjun Datt Law, et al.British Journal of Haematology|June 2, 2012
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocolSanthosh Thyagu, Mark D Minden, Vikas Gupta, et al.Annals of Hematology|February 20, 2017
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHDJoon Ho Moon, Nada Hamad, Sang Kyun Sohn, et al.Clinical Lymphoma, Myeloma & Leukemia|November 21, 2013
A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantationMohamed Shanavas, Hans A Messner, Suzanne Kamel-Reid, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantationJieun Uhm, Nada Hamad, Elizabeth M Shin, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI ScoreFotios V Michelis, Hans A Messner, Jieun Uhm, et al.Journal of Gastrointestinal Oncology|January 13, 2023
Outcomes of patients with esophageal cancer after allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Jonathan Yeung, Andrew Pierre, et al.Pageof 21